Guiding Multifactorial Clinical Decisions in HR+, HER2- Breast Cancer
57:00
Capitalizing on Personalized Care in IDH Mutant Gliomas
59:12
Making Precision Decisions in High-Risk HR+, HER2- Metastatic Breast Cancer
26:34
CDK 4/6 Inhibitors in Breast Cancer Advanced and Adjuvant Settings
1:05:27
#NSCLC updates from #MaTOS led by Drs. Stephen V. Liu & Zosia Piotrowska - bit.ly/LakeTahoe24Y
58:31
Stanford Cancer Institute Breakthroughs in Cancer: Luis Diaz, MD
28:42
Treatment of Metastatic Brain Disease: Whole Brain Radiotherapy vs. Stereotactic Radiosurgery
43:07
Improved Assessment of Severity and Novel Management Strategies to Alleviate the Burden of CRSwNP
29:04